|Written by Dr.Md.Redwanul Huq (Masum)|
|Sunday, 15 January 2012 16:12|
It is a type of chronic granulomatous infectious disease which is caused by Mycobacterium leprae involving skin, peripheral nerves, eye, upper respiratory tract and testes.
Classification of leprosy:
It can be classified as-
- Tuberculoid leprosy
- Bordenline tuberculoid leprosy
- Borderline leprosy
- Borderline lepromatous leprosy
- Lepromatous leprosy.
Clinical features of Tuberculoid leprosy:
1) Skin lesion –
a) Hyposthetic hypopigmented macule
b) Shiny skin with sharp erythematous margin
c) Centre of the lesion becomes atrophied and depressed.
2) Nerve lesion –
In this type of leprosy the following nerves can be thickened and palpable-
a) Ulner nerve near the elbow joint
b) Radial nerve near the wrist joint
c) Median nerve above the elbow and wrist joints
d) Popliteal nerve in the popliteal fossa
e) Great auricular nerve over sternocleidomastoid muscle
f) Posterior tibial nerve near medial malleolus.
Clinical features of Lepromatous leprosy:
1) Skin lesion –
a) Formation of numerous non- anaesthetic erythematous macules symmetrically involving the body
b) The lesions have ill defined margins
c) In advanced stage of the disease – there are diffuse thickening of the face, the eye brows, ear lobules and there is loss of eye lashes resulting the appearance of “Lionine facies”.
2) Nerve lesion –
Cardinal features of leprosy:
- Anaesthetic skin lesions ( in tuberculoid leprosy)
- Thickening of peripheral nerves
- Skin smears or biopsy shows acid-fast bacilli.
Treatment of leprosy:
Multidrug therapy regimens in treatment of leprosy (Modified WHO – recommended):
|Leprosy type||Monthly supervised drug treatment||Daily self administered drug treatment||Duration of treatment|
|Paucibacillary – single lesion leprosy||Ofloxacin 400 mg
Rifampicin 600 mg
Minocycline 100 mg
|Pauci -bacillary (2-5 skin lesions) leprosy||Rifampicin – 600 mg||Dapsone – 100 mg||6 months|
|Multi -bacillary||Rifampicin – 600 mgClofazimine – 300 mg||Clofazimine – 50 mg Dapsone – 100 mg||12 months|
Difference between Lepromatous Leprosy and Tuberculoid Leprosy:
|Traits||Lepromatous leprosy||Tuberculoid leprosy|
|Number and distribution of skin and nerve lesions||Widely disseminated||One or few sites, asymmetsically distributed|
|Clarity of margin of skin lesionElevation of margin of skin lesionColour of lesion in dark skinColour of lesion in light skinSurface of skin lesion
Central healing of the lesion
Sweat and hair growth
Loss of sensation
|PoorNeverSlight hypopigmentationSlight erythema
Smooth , shiny
|GoodCommonMarked hypopigmentationCoppery or red
Dry , scaly
Early and marked
|Nerve enlargement and damage||Late||Early and marked|
|Bacilli||Many (5/6 or more)||Absent|
Complications of leprosy:
- Anaesthesia of part or whole of the affected limb
- Exposure keratitis.
It is an acute exacerbation of clinical features that occurs due to an acute inflammation in pre-existing leprosy.
Types of Lepra reaction:
There are two types of Lepra reaction-
a) Type I
b) Type II
a) Type I:
Patients suffering from borderline tuberculoid leprosy develop this type of reaction where there are formation of new macules and rapid destruction of affected nerve(s).
Down grade reaction: When this reaction occurs before starting of the treatment.
Reversal reaction: When this reaction occurs after initiation of treatment.
Treatment of type I lepra reaction:
- In mild cases- Tab. Aspirin is given at a dose of 600 mg -6 hourly
- In severe cases – Tab. Prednisolone is given at a dose of 40 – 60 mg – daily for at least 3 months and then tapering the dose for 3 – 9 months.
b) Type II (Erythema nodusum leprosa):
Patients suffering from borderline lepromatous and lepromatous leprosy develop this type of reaction where there are formation of macules and development of fever and lymphadenitis. Usually type II lepra reaction occurs after beginning of the treatment within two years of time.
Treatment of type II lepra reaction:
- In mild cases – Tab. Aspirin is given at a dose of 600 mg -6 hourly.
- In severe cases – Tab. Prednisolone is given at a dose of 20 – 40 mg – daily for at least 2 weeks and then tapering the dose.